Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults

Stroke

Volumn 36, Issue 3, 2005, Pages 533-539

  Pezzini, Alessandro ^a   Grassi, Mario ^b   Del Zotto, Elisabetta ^a   Archetti, Silvana ^c   Spezi, Raffaella ^a   Vergani, Veronica ^a   Assanelli, Deodato ^c   Caimi, Luigi ^c   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Genetics; Risk factors; Stroke, ischemic

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADULT; ARTICLE; ATHEROGENESIS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

ADULT; ATTITUDE TO HEALTH; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 14844312067     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000155741.31499.c2     Document Type: Article

References (29)

1. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain. 2000;123: 1784-1812.
2. Dichgans M. Monogenic causes of ischemic stroke. In: Markus HS, ed. Stroke Genetics. Oxford, UK: Blackwell Science; 2003:127-163.
3. Flossman E, Schulz UGR, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004;35:212-227.
4. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet. 1996;13:429-434.
5. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, Gudmundsdottir T, Bjarnadottir SM, Einarsson OB, Gudjonsdottir HM, Hawkins M, Gudmundsson G, Gudmundsdottir H, Andrason H, Gudmundsdottir AS, Sigurdardottir M, Chou TT, Nahmias J, Goss S, Sveinbjornsdottir S, Valdimarsson EM, Jakobsson F, Agnarsson U, Gudnason V, Thorgeirsson G, Fingerle J, Gurney M, Gudbjartsson D, Frigge ML, Kong A, Stefansson K, Gulcher JR. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet. 2003;35:131-138.
6. Hassan A, Sham PC, Markus HS. Planning genetic studies in human stroke. Sample size estimates based on family history data. Neurology. 2002;58:1483-1488.
7. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate redictase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146:948-957.
8. Kelly PJ, Rosand J, Kistler JP, Shin VE, Silveira S, Plomaritoglou A, Furie KL. Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology. 2002;59:529-536.
9. Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke. 2000;31:1299-1306.
10. Pezzini A, Grassi M, Del Zotto E, Bazzoli E, Archetti S, Assanelli D, Maalikjy Akkawi N, Albenini A, Padovani A. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke. 2004;35:438-444.
11. Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albenini A, Grassi M, Assanelli D, Gasparotti R, Vignolo LA, Magoni M, Padovani A. Plasma homocysteine concentration, C677T MTHFR genotype and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33:664-669.
12. Johnson CJ, Kittner SJ, McCarter RJ, Sloan MA, Stern BJ, Buchholz D, Price TR. Interrater reliability of an etiologic classification of ischemic stroke. Stroke. 1995;26:46-51.
13. WHO Study Group on Diabetes Mellitus. World Health Organization Technical Report, Series 727. Geneva, Switzerland: World Health Organization; 1985.
14. Ripoll L, Paulin D, Drouet LO. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of Factor V Leiden and G20210A transition of the Prothrombin gene. Thromb Haemost. 1997;78:960-961.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
16. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31: 545-548.
17. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Control. 1974;19:716-723.
18. Botto LD, Khoury MJ. Facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol. 2001;153: 1016-1020.
19. Rothman KJ. Synergy and antagonism in cause-effect relationship. Am J Epidemiol. 1974;99:385-388.
20. Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, Dardik R, Baron Z, Seligsohn U. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood. 1999;39:2186-2190.
21. Doggen CJ, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation. 1998;97:1037-1041.
22. Siscovick DS, Schwartz SM, Rosendaal FR, Psaty BM. Thrombosis in the young: effects of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors. Thromb Haemost. 1997; 78:7-12.
23. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L, Bene J, Melegh B. Evaluation of the modifying effects of unfavorable genotypes on classical clinical risk factors for ischaemic stroke. J Neurol Neurosurg Psychiatry. 2003;74:1615-1620.
24. Glueck CJ, Fontaine RN, Wang P. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke. Thromb Haemost. 2000;85:256-259.
25. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol. 2002;49:1391-1397.
26. Rees DC, Cox M, Clegg JB. World distribution of Factor V Leiden. Lancet. 1995;346:1133-1134.
27. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke AA, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79:706-708.
28. Margaglione M, Seripa D, Gravina C, Grandone E, Vecchione G, Cappucci G, Merla G, Papa S, Postiglione A, Di Minno G, Fazio VM. Prevalence of apolipoproteine E alleles in healthy subjects and survivors of ischemic stroke. An Italian case-control study. Stroke. 1998;29: 399-403.
29. Missiaglia E, Tosetto A, Rodeghiero F. The VITA project: risk of venous thromboembolism and C677T mutation of the MTHFR gene (Abstract). Thromb Haemost. 1997;(suppl):393.